| Literature DB >> 24786089 |
Abstract
Identifying trace amounts of bacteria rapidly, accurately, selectively, and with high sensitivity is important to ensuring the safety of food and diagnosing infectious bacterial diseases. Microbial diseases constitute the major cause of death in many developing and developed countries of the world. The early detection of pathogenic bacteria is crucial in preventing, treating, and containing the spread of infections, and there is an urgent requirement for sensitive, specific, and accurate diagnostic tests. Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) is an extremely selective and sensitive analytical tool that can be used to characterize different species of pathogenic bacteria. Various functionalized or unmodified nanomaterials can be used as affinity probes to capture and concentrate microorganisms. Recent developments in bacterial detection using nanomaterials-assisted MALDI-MS approaches are highlighted in this article. A comprehensive table listing MALDI-MS approaches for identifying pathogenic bacteria, categorized by the nanomaterials used, is provided.Entities:
Mesh:
Year: 2014 PMID: 24786089 PMCID: PMC4057671 DOI: 10.3390/ijms15057266
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Nanomaterials used as affinity probes in MALDI-MS.
| Nanomaterials | Functionalized molecule | Pathogen | Application | LOD (cfu/mL) | Ref. |
|---|---|---|---|---|---|
| Fe3O4 NPs | IgG | 3.0 × 105 | [ | ||
| Fe3O4 NPs | IgG | Urine | 3.0×107 | [ | |
| Fe3O4 NPs | Vancomycin | Urine | 7.8 × 104; 7.4 × 104 | [ | |
| Fe3O4 NPs | Vancomycin | Tap water, reservoir water | 5.0 × 102 | [ | |
| Ag NPs | N.D. | [ | |||
| Ag NPs | Yogurt | N.D. | [ | ||
| Ag NPs | Yogurt | N.D. | [ | ||
| CdS QDs | N.D. | [ | |||
| CdS QDs | N.D. | [ | |||
| CdS QDs | Chitosan | 2.0 × 102; 1.5 × 102 | [ | ||
| Pt NPs | Mixed with ionic liquid (1-butyl-3-methylimidazolium hexafluorophosphate) | 106 | [ | ||
| Pt NPs | IgG | Rhizospheric soil and root | N.D. | [ | |
| Pt NPs | IgG | 105 | [ | ||
| AuNCs | Lysozyme | Fetal bovine serum; urine | N.D.; 106 | [ | |
| Graphene magnetic nanosheets | Chitosan | Blood | 6.0 × 102; 5.0 × 102 | [ | |
| NiO NPs | 107 | [ | |||
| TiO2 NPs | Human nasal passage | N.D. | [ | ||
| ZnO NPs | N.D. | [ | |||
| Ag, Pt, NiO, TiO2, ZnO NPs | N.D. | [ |
Ref., Reference; Ag, silver; AuNCs, gold nanoclusters; CdS, cadmium sulfide; IgG, immunoglobulin; LOD, limit of detection; N.D., not determined; NiO, nickel oxide; NPs, nanoparticles; Pt, platinum; QDs, quantum dots; TiO2, titanum dioxide; ZnO, zinc oxide.
Figure 1.Synthetic route for immobilizing immunoglobulin (IgG) onto the surfaces of Fe3O4 magnetic nanoparticles. Reprinted with permission from [66]. Copyright (2014) American Chemical Society.
Figure 2.Cartoon illustrations of the proposed method for anchoring vancomycin-immobilized magnetic nanoparticles onto the surface of a Gram-positive bacterial cell and the binding of vancomycin to the terminal of D-Alanine (D-Ala)–D-Ala units of the peptides on the cell wall of a Gram-positive bacterium. Reprinted with permission from [67]. Copyright (2014) American Chemical Society.
Figure 3.Photographs obtained by vortex-mixing (A) the lysozyme-AuNCs with E. coli J96 at different cell concentrations and (B) E. coli J96 alone for 1 h at different cell concentrations, followed by centrifugation at 3500 rpm for 5 min. The samples were prepared in urine that was diluted 50-fold with PBS solution (pH 7.4) containing BSA (~10 μM). The photographs were taken under illumination of UV light (λmax = 365 nm); (C) Examination of the limit of detection. Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) obtained after using the lysozyme-AuNCs (1.36 mg/mL, 0.1 mL) as affinity probes to concentrate target species from a urine sample (0.90 mL) containing E. coli J96 (1.59 × 106 cells/mL) for 1 h. The urine sample was diluted 50-fold with PBS solution (pH 7.4) containing BSA (~10 μM) prior to bacterial spiking. Reprinted with permission from [77].
Figure 4.Schematic diagram showing the mechanisms (Mechanism A and Mechanism B) for interactions of five nanoparticles with two pathogenic bacteria postulated in the study. Reprinted with permission from [82].